In patients with remitting inflammatory bowel disease, relapse after withdrawal of anti-tumor necrosis factor therapy is less likely if they have complete endoscopic healing, suggests a Dutch study.
Medscape Medical News
In patients with remitting inflammatory bowel disease, relapse after withdrawal of anti-tumor necrosis factor therapy is less likely if they have complete endoscopic healing, suggests a Dutch study.
Medscape Medical News
